Interview with Michele Garot, Vice President, BeCRO
What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the…
Address: Sint lambertusstraat 141 Rue Saint LambertB- 1200 Brussels,Belgium
Tel:
Web: http://www.becro.be/
BeCRO is the Belgian Association of CRO’s. BeCRO was initially founded by 19 member companies and has now grown to include 32 active members, representing more than a third of the 83 identified CRO’s in the country in 2011.
The aims of BeCRO are:
– To establish an association of service and consultancy companies active in pharmaceutical and medical development for health products, companies involved in the running of complete preclinical or clinical trials or parts thereof,- To represent and defend the interests of such companies to health authorities, companies, institutions and organisations operating in the health sector,- To be recognised as a privileged interlocutor by health authorities, any professional bodies and any national or international association and/or federation,- To establish good operating practices, with respect as regards highest quality rules and Good Clinical Practices,- To work towards training its members,- To promote the association.
What was the motivation behind the establishment of BeCRO and why was it only established in 2010 given the…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…